Seguir
Martin Strassnig
Martin Strassnig
Associate Professor of Psychiatry
Dirección de correo verificada de scmhcinc.org
Título
Citado por
Citado por
Año
Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status
PD Harvey, M Strassnig
World Psychiatry 11 (2), 73-79, 2012
3542012
Nutritional assessment of patients with schizophrenia: a preliminary study
M Strassnig, JS Brar, R Ganguli
Schizophrenia Bulletin 29 (2), 393-397, 2003
2282003
Determinants of different aspects of everyday outcome in schizophrenia: the roles of negative symptoms, cognition, and functional capacity
MT Strassnig, T Raykov, C O'Gorman, CR Bowie, S Sabbag, D Durand, ...
Schizophrenia research 165 (1), 76-82, 2015
2162015
Body mass index and quality of life in community-dwelling patients with schizophrenia
M Strassnig, JS Brar, R Ganguli
Schizophrenia research 62 (1-2), 73-76, 2003
1842003
Risperidone plasma levels, clinical response and side–effects
M Riedel, MJ Schwarz, M Strassnig, I Spellmann, A Müller–Arends, ...
European archives of psychiatry and clinical neuroscience 255, 261-268, 2005
1712005
Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis
M Strassnig, J Miewald, M Keshavan, R Ganguli
Schizophrenia research 93 (1-3), 90-98, 2007
1662007
Prediction of disability in schizophrenia: Symptoms, cognition, and self-assessment
PD Harvey, MT Strassnig, J Silberstein
Journal of Experimental Psychopathology 10 (3), 2043808719865693, 2019
1252019
Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia
M Strassnig, JS Brar, R Ganguli
Schizophrenia research 126 (1-3), 103-109, 2011
1162011
About a peculiar disease of the cerebral cortex: Alzheimer's original case revisited
M Strassnig, M Ganguli
Psychiatry (Edgmont) 2 (9), 30, 2005
1152005
Quetiapine in the treatment of schizophrenia and related disorders
M Riedel, N Müller, M Strassnig, I Spellmann, E Severus, HJ Möller
Neuropsychiatric disease and treatment 3 (2), 219-235, 2007
1142007
Factors influencing self-assessment of cognition and functioning in schizophrenia: implications for treatment studies
D Durand, M Strassnig, S Sabbag, F Gould, EW Twamley, TL Patterson, ...
European Neuropsychopharmacology 25 (2), 185-191, 2015
1002015
Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia
CA Depp, M Strassnig, BT Mausbach, CR Bowie, P Wolyniec, ...
Bipolar disorders 16 (4), 422-431, 2014
952014
Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia
M Strassnig, JS Brar, R Ganguli
Schizophrenia research 86 (1-3), 269-275, 2006
942006
Decreased T cellular immune response in schizophrenic patients
M Riedel, I Spellmann, MJ Schwarz, M Strassnig, C Sikorski, HJ Möller, ...
Journal of psychiatric research 41 (1-2), 3-7, 2007
912007
Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia?
M Strassnig, C Bowie, AE Pinkham, D Penn, EW Twamley, TL Patterson, ...
Journal of psychiatric research 104, 124-129, 2018
832018
Physical performance and disability in schizophrenia
M Strassnig, J Signorile, C Gonzalez, PD Harvey
Schizophrenia Research: Cognition 1 (2), 112-121, 2014
822014
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms
M Riedel, I Spellmann, M Strassnig, A Douhet, S Dehning, ...
European archives of psychiatry and clinical neuroscience 257, 360-370, 2007
812007
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms
M Riedel, N Müller, M Strassnig, I Spellmann, RR Engel, R Musil, ...
European archives of psychiatry and clinical neuroscience 255, 432-437, 2005
802005
How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?
M Riedel, M Strassnig, N Müller, P Zwack, HJ Möller
European archives of psychiatry and clinical neuroscience 255, 143-148, 2005
782005
Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia
M Strassnig, JS Brar, R Ganguli
Schizophrenia research 76 (2-3), 343-351, 2005
722005
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20